News | June 03, 2013

Michigan Breast Oncology Quality Initiative Selects ArborMetrix's Clinical Registry and Analytics Platform

Solution will help 26 hospitals and more than 400 oncologists enhance breast cancer care and clinical quality

June 3, 2013 — ArborMetrix Inc., a provider of real-time healthcare analytics, announced that the Michigan Breast Oncology Quality Initiative (MiBOQI) selected its fully integrated, cloud-based registry and analytics solution to replace its legacy system. The 26-hospital Collaborative Quality Initiative (CQI) will implement ArborMetrix's technology to improve quality, safety, outcomes and effectiveness of breast cancer treatment across the state of Michigan.

"When our existing vendor discontinued its product, it gave us the perfect opportunity to seek a more advanced, powerful and sophisticated solution," said Samuel Silver, M.D., Ph.D., project director at MiBOQI and assistant dean for research and professor of internal medicine/hematology-oncology at the University of Michigan Medical School. "After thoroughly evaluating half a dozen companies, we selected ArborMetrix because of their successful track record in converting and customizing legacy data. They offer the most proven, powerful, configurable and flexible tool, and they're willing and able to modify our database on demand. The fact that Dr. John Birkmeyer [the company's founder and chief scientific officer] is a renowned quality and outcomes improvement researcher was one more factor that made it attractive for us to partner with them." 

Unlike guidelines for other medical conditions, protocols for breast cancer change frequently due to new discoveries and medications. The 26 hospitals and 420 medical, surgical and radiation oncologists that participate in MiBOQI follow nationally accepted guidelines from the National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 23 of the world's leading cancer centers. Over the first 4.5 months of 2013, NCCN has revised its breast cancer guidelines three times. In comparison, other organizations typically issue guidelines every three years. 

"I expect NCCN to release three additional versions by year-end," said Silver, who is also NCCN's chair. "ArborMetrix will allow MiBOQI not only to keep pace with NCCN but analyze our data more expeditiously to measure and report on clinical performance; improve breast cancer diagnosis and care; identify and determine best practices; and ensure adherence to evidence-based guidelines. It will facilitate a more rapid learning cycle, positioning MiBOQ to deliver actionable information to physicians much sooner than we could before, helping them enhance care and save more lives." 

Breast cancer is the second leading cause of cancer deaths and is the most frequently diagnosed cancer among Michigan women, according to the American Cancer Society. MiBOQI, a CQI sponsored by Blue Cross Blue Shield of Michigan and Blue Care Network, has been tracking data of 25,000 women with breast cancer since its founding in 2006. MiBOQI will go live with ArborMetrix this summer. 

"Hospitals today are under continuous pressure to deliver high-quality care at lower cost," said Brett Furst, CEO of ArborMetrix. "We are pleased Michigan Breast Oncology Quality Initiative chose us to navigate that challenge and look forward to supporting their efforts to provide state-of-the-art breast cancer treatment throughout Michigan." 

For more information: www.miboqi.cms.si.umich.edu, www.arbormetrix.com

Related Content

Collaboration will include data sharing, R&D and an upgrade of RadNet’s fleet of mammography systems to Hologic’s state-of-the-art imaging technology
News | Breast Imaging | August 06, 2020
August 6, 2020 — RadNet, Inc., a national leader in providing hig
Intelerad Medical Systems, a leader in enterprise workflow solutions, announced the acquisition of Radius, a private cloud platform provider based in the Nashville, Tenn., metropolitan area.
News | Enterprise Imaging | August 05, 2020
August 5, 2020 — Intelerad Medical Systems, a leader in enterprise workflow solutions, announced the acquisition of
Keeping the health and safety of of the HIMSS audience in mind, the conference moves to August 9-13 in Las Vegas
News | HIMSS | August 03, 2020
August 3, 2020 —  The Healthcare Informatio...
Hologic, Inc. launched the Back to Screening campaign encouraging women to schedule their annual mammograms now that healthcare facilities across the nation are re-opening their doors following closures due to the COVID-19 pandemic.

Nine-time GRAMMY Award winner and breast cancer survivor Sheryl Crow has served as the spokesperson for Hologic’s Genius 3D Mammography exam for nearly five years.

News | Breast Imaging | August 03, 2020
August 3, 2020 — Hologic, Inc. launched the Back to Screening campaign encouraging women to schedule their ann
It covers every major modality, including breast imaging/mammography, fixed and portable C-arms (cath, IR/angio, hybrid, OR), CT, MRI, nuclear medicine, radiographic fluoroscopy, ultrasound and X-ray
News | Radiology Imaging | July 29, 2020
July 29, 2020 — IMV Medical Information, part of Scien...
Candelis, Inc., a leading provider of innovative and cost-effective enterprise healthcare solutions, and VasoTechnololgy, a subsidiary of the Vaso Corporation, announced an agreement to distribute Candelis' suite of image management PACS solutions and cloud services, including ImageGrid, ImageGrid Mini PACS and ASTRA Cloud.
News | Enterprise Imaging | July 29, 2020
July 29, 2020 — Candelis, Inc., a leading provider of innovative and cost-effective enterprise healthcare solutions,
Zebra Medical Vision announced its sixth FDA 510(k) clearance for its mammography solution, HealthMammo, which has already received a CE mark. Zebra Medical’s algorithm empowers breast radiologists by prioritizing and identifying suspicious mammograms, providing a safety net for radiologists. The suspicious mammograms are identified faster and read earlier than the current “first-in first-out” standard of care. 
News | Breast Imaging | July 27, 2020
July 26, 2020 —  Zebra Medical Vision announced its sixth FDA 510